Viewing Study NCT03276832


Ignite Creation Date: 2025-12-24 @ 9:43 PM
Ignite Modification Date: 2026-01-31 @ 8:43 PM
Study NCT ID: NCT03276832
Status: COMPLETED
Last Update Posted: 2025-10-28
First Post: 2017-09-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV Melanoma
Sponsor: Mayo Clinic
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Melanoma View
None Stage IIIB Cutaneous Melanoma AJCC v7 View
None Stage IIIC Cutaneous Melanoma AJCC v7 View
None Stage IV Cutaneous Melanoma AJCC v6 and v7 View
Keywords: